Home / Health / AI Spots Deadly Cancer Before Symptoms Appear
AI Spots Deadly Cancer Before Symptoms Appear
2 Jan
Summary
- AI tool PANDA detects pancreatic cancer from noncontrast CT scans.
- Alibaba's AI tool received 'breakthrough device' status from FDA.
- AI technology helped save numerous lives by early tumor detection.
An innovative AI tool, PANDA, is transforming early pancreatic cancer detection in China. Developed by researchers affiliated with Alibaba, the system analyzes noncontrast CT scans, which typically yield less detailed images, to identify potential tumors. This technology has been instrumental in flagging cases where initial scans showed no obvious abnormalities, leading to early diagnoses and life-saving interventions.
At the Affiliated People's Hospital of Ningbo University, the PANDA system has analyzed over 180,000 CT scans since November 2024, aiding in the detection of approximately two dozen pancreatic cancer cases. Fourteen of these were identified in their early stages, significantly improving patient prognosis. The tool's effectiveness in identifying subtle signs of cancer in lower-radiation scans has been validated, with a study in Nature Medicine reporting a 93% accuracy rate in identifying lesions.
Alibaba's PANDA has garnered 'breakthrough device' status from the U.S. Food and Drug Administration, signaling its potential for expedited market entry. While experts acknowledge the need for more real-world data, the technology offers a promising solution for combating pancreatic cancer, one of the deadliest forms, by enabling earlier detection when treatment is most effective.
